Isoniazid resistance and the future of drug-resistant tuberculosis.
about
Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosisAntiviral resistance and the control of pandemic influenzaSpontaneous emergence of multiple drug resistance in tuberculosis before and during therapyActivity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosisMultidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testingGenetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic reviewCorrelations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.Isoniazid-resistant tuberculosis: a cause for concern?Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.Whole genome sequencing to complement tuberculosis drug resistance surveys in UgandaManagement of multidrug-resistant tuberculosis: Update 2007.Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?Investigation of Ser315 substitutions within katG gene in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from south India.Nε- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are Acetylated.Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
P2860
Q28469011-BB828F49-1AFB-4182-A3D3-224C4196F7F7Q28469119-3A90C766-B3B6-456F-ACF0-E65DFD1C1CA1Q28477566-FE45ED1B-D430-49F6-BC30-72719625E916Q28483265-FF94BAA3-7A56-4F92-9354-921106E5A76CQ28485230-143A5F2C-990E-42B5-B76A-B8E9FF2B0AA8Q28544877-06D89D74-9748-49B1-BB03-59DA4B48D214Q33410693-DD3FDB2A-FC80-4367-813B-D1D5F2334B78Q33820505-7A296EF5-9FE8-454B-BB4A-DA660F2A3624Q34974987-ABE99CF4-6E5C-4A08-B0EB-98FFED308365Q35065085-142FA4E3-272D-498E-A456-F5CD93621C86Q36869848-9C088AB2-ECF9-45D4-9CD3-5CAC556781A3Q37058166-F75208F9-6AC7-4D9D-9804-CE8332BD9BFCQ37373820-8BD7EA0D-FBAB-4A4B-82AE-9219278A39D0Q38040818-76050970-34A8-449C-94A0-2539CCEA2A28Q42180778-D6AA0E84-BE7B-443C-8D35-53EC1FB97616Q42691239-D4BB9790-3D6D-4C17-A112-D1AF0EFC1FF1Q49820077-3C787DBE-44E1-40B5-B10B-D55BD14829F0
P2860
Isoniazid resistance and the future of drug-resistant tuberculosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isoniazid resistance and the future of drug-resistant tuberculosis.
@en
Isoniazid resistance and the future of drug-resistant tuberculosis.
@nl
type
label
Isoniazid resistance and the future of drug-resistant tuberculosis.
@en
Isoniazid resistance and the future of drug-resistant tuberculosis.
@nl
prefLabel
Isoniazid resistance and the future of drug-resistant tuberculosis.
@en
Isoniazid resistance and the future of drug-resistant tuberculosis.
@nl
P2093
P2860
P356
P1476
Isoniazid resistance and the future of drug-resistant tuberculosis.
@en
P2093
Megan B Murray
Mercedes C Becerra
P2860
P304
P356
10.1089/MDR.2004.10.280
P577
2004-01-01T00:00:00Z